Change in the prevalence of cataract blindness · people with vision impairment caused by cataract
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Prevalence of visual impairment due to cataract · people with vision impairment caused by cataract
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Complete release of vitreous adhesion · people with symptomatic vitreomacular adhesion
Ocriplasmin injection leads to higher complete release of vitreous adhesion compared with control (high certainty).
1 finding from 1 review
RR 3.46 [2, 6]
Studies not reported
High
Closure of macular hole · people with symptomatic vitreomacular adhesion
Ocriplasmin injection leads to higher closure of macular hole compared with control (high certainty).
1 finding from 1 review
RR 2.87 [1.5, 5.51]
Studies not reported
High
Complete posterior vitreous detachment · people with symptomatic vitreomacular adhesion
Ocriplasmin injection leads to higher complete posterior vitreous detachment compared with control (high certainty).
1 finding from 1 review
RR 2.94 [1.39, 6.24]
Studies not reported
High
3‐line or greater improvement in best‐corrected visual acuity · people with symptomatic vitreomacular adhesion
Ocriplasmin injection probably leads to higher 3‐line or greater improvement in best‐corrected visual acuity compared with control (moderate certainty).
1 finding from 1 review
RR 1.95 [1.07, 3.53]
Studies not reported
Moderate
Requirement for vitrectomy · people with symptomatic vitreomacular adhesion
Ocriplasmin injection probably leads to lower requirement for vitrectomy compared with control (moderate certainty).
1 finding from 1 review
RR 0.67 [0.5, 0.91]
Studies not reported
Moderate
Mean change in validated visual function questionnaire score from baseline Score ranges from 0 to 100, higher scores are better visual function · people with symptomatic vitreomacular adhesion
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
Adverse events (ocular problems) · people with symptomatic vitreomacular adhesion
Ocriplasmin injection probably leads to higher any ocular adverse event compared with control (moderate certainty).
1 finding from 1 review
RR 1.22 [1.09, 1.37]
Studies not reported
Moderate
Intervention not reported
Improvement in symptoms, reported by the child or by their parents/carers, preferably measured by a validated tool, at three months (± one month) after start of treatment · children with blepharokeratoconjunctivitis
1 finding from 1 review
Intervention not reported
Elimination of all clinical signs of ocular surface inflammation ('complete success'), preferably measured by a composite grading system, at three months (± one month) after start of treatment · children with blepharokeratoconjunctivitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Improvement of clinical signs of ocular surface inflammation ('partial success'), preferably measured by a composite grading system, at three months (± one month) after start of treatment · children with blepharokeratoconjunctivitis
1 finding from 1 review
no estimate extracted
137 participants
Very low
Intervention not reported
Change from baseline in best corrected visual acuity in affected eye(s) in logMAR · children with blepharokeratoconjunctivitis
1 finding from 1 review
Intervention not reported
Uncontrolled or poorly controlled disease progression due to treatment failure, at three months (± one month) after start of treatment · children with blepharokeratoconjunctivitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Adverse effects of medication, at any time during treatment · children with blepharokeratoconjunctivitis
1 finding from 1 review
Intervention not reported
Quality of life · children with blepharokeratoconjunctivitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of participants with postoperative surgical success (hypertropia less than 3 PD in primary gaze) · people with symptom‐producing and/or socially noticeable unilateral overacting inferior oblique muscle; all participants had longstanding…
1 finding from 1 review
Proportion of participants with postoperative hypertropia less than 3 PD in down gaze · people with unilateral superior oblique palsy
1 finding from 1 review
Proportion of participants with postoperative hypertropia less than 3 PD in contralateral gaze · people with unilateral superior oblique palsy
1 finding from 1 review
Proportion of participants who received additional strabismus surgery · people with unilateral superior oblique palsy
It is very uncertain whether inferior oblique disinsertion changes proportion of participants who received additional strabismus surgery compared with anterior transposition (very low certainty).
1 finding from 1 review